comprehensive
Previous article:
Medicare proposal to cover medical devices draws a mixed reaction
Next article: Cassava reveals details — and problems — with Alzheimer's study
Next article: Cassava reveals details — and problems — with Alzheimer's study
leisure time
knowledge
-
Intercept Pharmaceuticals sells itself for less than $1 billion
2025-09-27 10:00 -
Readout Newsletter: What happened with Sarepta's Duchenne data
2025-09-27 09:58 -
Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
2025-09-27 09:48 -
Did you have Obamacare on your GOP debate bingo card?
2025-09-27 09:08 -
Senate panel to vote on hospitals, PBMs, prisoner care
2025-09-27 07:41 -
Biden's order seeks to regulate AI risk without stifling innovation
2025-09-27 07:28